Retrospective Assessment of Cost Savings from Prevention: Folic Acid Fortification and Spina Bifida in the U.S.

American Journal of Preventive Medicine

Volumn 50, Issue 5, 2016, Pages S74-S80

  Grosse, Scott D ^a   Berry, Robert J ^a   Mick Tilford, J ^b   Kucik, James E ^c   Waitzman, Norman J ^d  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID;

ADOLESCENT; ADULT; ARTICLE; CEREAL; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DISEASE SURVEILLANCE; FEMALE; FOLIC ACID FORTIFICATION; FOOD AND DRUG ADMINISTRATION; FOOD PROCESSING; HEALTH CARE COST; HUMAN; INFANT; LIVE BIRTH; MAJOR CLINICAL STUDY; RETROSPECTIVE STUDY; SPINAL DYSRAPHISM; UNITED STATES; FORTIFIED FOOD; PHYSIOLOGY; PREGNANCY; PREVALENCE; STANDARDS;

COST SAVINGS; FEMALE; FOLIC ACID; FOOD, FORTIFIED; HUMANS; INFANT; PREGNANCY; PREVALENCE; RETROSPECTIVE STUDIES; SPINAL DYSRAPHISM;

EID: 84953791543     PISSN: 07493797     EISSN: 18732607     Source Type: Journal    
DOI: 10.1016/j.amepre.2015.10.012     Document Type: Article

References (66)

1. A.E. Czeizel, and I. Dudas Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation N Engl J Med 327 26 1992 1832 1835 10.1056/NEJM199212243272602
2. MRC Vitamin Study Research Group Prevention of neural tube defects: results of the Medical Research Council Vitamin Study Lancet 338 8760 1991 131 137 10.1016/0140-6736(91)90133-A
3. U.S. Food and Drug Administration Food standards: amendments of standards of identity for enriched grain products to require addition of folic acid Federal Register 61 1996 8781 8797
4. CDC CDC Grand Rounds: additional opportunities to prevent neural tube defects with folic acid fortification MMWR Morb Mortal Wkly Rep 59 31 2010 980 984
5. R.E. Glasgow, and J.F. Steiner Comparative effectiveness research to accelerate translation: Recommendations for an emerging field of science R.C. Brownson, G.A. Colditz, E.K. Proctor, Dissemination and Implementation Research in Health 2012 Oxford University Press New York, NY 72 92 10.1093/acprof:oso/9780199751877.003.0004
6. P.S. Romano, N.J. Waitzman, R.M. Scheffler, and R.D. Pi Folic acid fortification of grain: an economic analysis Am J Public Health 85 5 1995 667 676 10.2105/AJPH.85.5.667
7. A.E. Kelly, A.C. Haddix, K.S. Scanlon, C.G. Helmick, and J. Mulinare Cost-effectiveness of strategies to prevent neural tube defects M.R. Gold, J.E. Siegel, L.B. Russell, M.C. Weinstein, Cost-Effectiveness in Health and Medicine 1996 Oxford University Press New York, NY 312 349
8. U.S. Food and Drug Administration Food standards: amendment of the standards of identity for enriched grain products to require addition of folic acid Federal Register 58 1993 53305 53312
9. L.E. Daly, P.N. Kirke, A. Molloy, D.G. Weir, and J.M. Scott Folate levels and neural tube defects. Implications for prevention JAMA 274 21 1995 1698 1702 10.1001/jama.1995.03530210052030
10. N.J. Wald, M.R. Law, J.K. Morris, and D.S. Wald Quantifying the effect of folic acid Lancet 358 9298 2001 2069 2073 10.1016/S0140-6736(01)07104-5
11. K.S. Crider, O. Devine, L. Hao, and et al. Population red blood cell folate concentrations for prevention of neural tube defects: Bayesian model BMJ 349 2014 g4554 10.1136/bmj.g4554
12. S.D. Grosse, N.J. Waitzman, P.S. Romano, and J. Mulinare Reevaluating the benefits of folic acid fortification in the United States: economic analysis, regulation, and public health Am J Public Health 95 11 2005 1917 1922 10.2105/AJPH.2004.058859
13. J. Williams, C.T. Mai, J. Mulinare, and et al. Updated estimates of neural tube defects prevented by mandatory folic acid fortification - United States, 1995-2011 MMWR Morb Mortal Wkly Rep 64 1 2015 1 5
14. S.E. Parker, C.T. Mai, M.A. Canfield, and et al. Updated national birth prevalence estimates for selected birth defects in the United States, 2004-2006 Birth Defects Res A Clin Mol Teratol 88 12 2010 1008 1016 10.1002/bdra.20735
15. J.A. Martin, B.E. Hamilton, M.J. Osterman, S.C Curtin, and T.J Mathews Births: final data for 2012 Natl Vital Stat Rep 62 9 2013 1 68
16. S.C. Tinker, H.C. Hamner, and Y.P. Qi Crider K.S.U.S. women of childbearing age who are at possible increased risk of a neural tube defect-affected pregnancy due to suboptimal red blood cell folate concentrations, National Health and Nutrition Examination Survey 2007 to 2012 Birth Defects Res A Clin Mol Teratol 103 6 2015 517 526 10.1002/bdra.23378
17. U.S. Food and Drug Administration Food additives permitted for direct addition to food for human consumption; folic acid (folacin), final rule Federal Register 61 1996 8797 8807
18. C.M. Pfeiffer, J.P. Hughes, D.A. Lacher, and et al. Estimation of trends in serum and RBC folate in the U.S. population from pre- to postfortification using assay-adjusted data from the NHANES 1988-2010 J Nutr 142 5 2012 886 893 10.3945/jn.111.156919
19. C.M. Pfeiffer, C.L. Johnson, R.B. Jain, and et al. Trends in blood folate and vitamin B-12 concentrations in the United States, 1988-2004 Am J Clin Nutr 86 3 2007 718 727
20. M.R. Gold, J.E. Siegel, L.B. Russell, and M.C. Weinstein Cost-Effectiveness in Health and Medicine 1996 Oxford University Press New York, NY
21. S.D. Grosse, L. Ouyang, J.S. Collins, D. Green, J.H. Dean, and R.E. Stevenson Economic evaluation of a neural tube defect recurrence-prevention program Am J Prev Med 35 6 2008 572 577 10.1016/j.amepre.2008.07.008
22. M.E. Drummond, B. O'Brien, G.L. Stoddart, and G.W. Torrance Methods for the Economic Evaluation of Health Care Programmes 2nd ed. 1997 Oxford Univiversity Press Oxford
23. N.J. Waitzman, P.S. Romano, and R.M. Scheffler The Cost of Birth Defects 1996 University Press of America Lanham, MD
24. N.J. Waitzman, P.S. Romano, and S.D. Grosse Half-life of cost of illness estimates: The case of spina bifida D.F. Wyszynski, Neural Tube Defects: From Origin to Treatment 2005 Oxford University Press New York, NY 342 351
25. L. Ouyang, S.D. Grosse, B.S. Armour, and N.J. Waitzman Health care expenditures of children and adults with spina bifida in a privately insured U.S. population Birth Defects Res A Clin Mol Teratol 79 7 2007 552 558 10.1002/bdra.20360
26. M. Shin, J.E. Kucik, C. Siffel, and et al. Improved survival among children with spina bifida in the United States J Pediatr 161 6 2012 1132 1137 10.1016/j.jpeds.2012.05.040
27. CDC Hospital stays, hospital charges, and in-hospital deaths among infants with selected birth defects - United States, 2003 MMWR Morb Mortal Wkly Rep 56 2 2007 25 29
28. J.M. Tilford, S.D. Grosse, A.C. Goodman, and K. Li Labor market productivity costs for caregivers of children with spina bifida: a population-based analysis Med Decis Making 29 1 2009 23 32 10.1177/0272989X08322014
29. J.S. Collins, K.K. Atkinson, J.H. Dean, R.G. Best, and R.E. Stevenson Long term maintenance of neural tube defects prevention in a high prevalence state J Pediatr 159 1 2011 143 149 10.1016/j.jpeds.2010.12.037
30. S.E. Parker, M.M. Yazdy, A.A. Mitchell, L.A. Demmer, and M.M. Werler A description of spina bifida cases and co-occurring malformations, 1976-2011 Am J Med Genet A 164 2 2014 432 440 10.1002/ajmg.a.36324
31. P. De Wals, F. Tairou, M.I. Van Allen, and et al. Spina bifida before and after folic acid fortification in Canada Birth Defects Res A Clin Mol Teratol 82 9 2008 622 626 10.1002/bdra.20485
32. E. Wittenberg, and L.A. Prosser Disutility of illness for caregivers and families: a systematic review of the literature Pharmacoeconomics 31 6 2013 489 500 10.1007/s40273-013-0040-y
33. D.R. Rappange, P.H. van Baal, N.J. van Exel, T.L. Feenstra, F.F. Rutten, and W.B. Brouwer Unrelated medical costs in life-years gained: should they be included in economic evaluations of healthcare interventions? Pharmacoeconomics 26 10 2008 815 830 10.2165/00019053-200826100-00003
34. S.D. Grosse, A.L. Flores, L.J. Ouyang, J.M. Robbins, and J.M. Tilford Impact of spina bifida on parental caregivers: findings from a survey of Arkansas families J Child Fam Stud 18 5 2009 574 581 10.1007/s10826-009-9260-3
35. K.J. Sawin, T. Liu, E. Ward, and et al. The National Spina Bifida Patient Registry: profile of a large cohort of participants from the first 10 clinics J Pediatr 166 2 2015 444 450 10.1016/j.jpeds.2014.09.039
36. H.C. Hamner, S.C. Tinker, A.L. Flores, J. Mulinare, A.P. Weakland, and N.F. Dowling Modelling fortification of corn masa flour with folic acid and the potential impact on Mexican-American women with lower acculturation Public Health Nutr 16 5 2013 912 921 10.1017/S1368980012004582
37. J.A. Gwirtz, and M.N. Garcia-Casal Processing maize flour and corn meal food products Ann N Y Acad Sci 1312 2014 66 75 10.1111/nyas.12299
38. H.C. Hamner, and S.C. Tinker Fortification of corn masa flour with folic acid in the United States: an overview of the evidence Ann N Y Acad Sci 1312 2014 8 14 10.1111/nyas.12325
39. S.C. Tinker, O. Devine, C. Mai, and et al. Estimate of the potential impact of folic acid fortification of corn masa flour on the prevention of neural tube defects Birth Defects Res A Clin Mol Teratol 97 10 2013 649 657 10.1002/bdra.23158
40. R.J. Berry, Z. Li, J.D. Erickson, and et al. for the China-U.S. Collaborative Project for Neural Tube Defect Prevention. Prevention of neural-tube defects with folic acid in China N Engl J Med 341 20 1999 1485 1490 10.1056/NEJM199911113412001
41. P. De Wals, F. Tairou, M.I. Van Allen, and et al. Reduction in neural-tube defects after folic acid fortification in Canada N Engl J Med 357 2 2007 135 142 10.1056/NEJMoa067103
42. J.S. Lopez-Camelo, E.E. Castilla, and I.M. Orioli Folic acid flour fortification: impact on the frequencies of 52 congenital anomaly types in three South American countries Am J Med Genet A 152A 10 2010 2444 2458 10.1002/ajmg.a.33479
43. R.J. Berry, J. Mulinare, and H.C. Hamner Folic acid fortification: neural tube defect risk reduction - a global perspective L.B. Bailey, Folate in Health and Disease 2nd ed. 2010 CRC Press Boca Raton, FL 179 204
44. K.S. Crider, L.B. Bailey, and R.J. Berry Folic acid food fortification-its history, effect, concerns, and future directions Nutrients 3 3 2011 370 384 10.3390/nu3030370
45. A. Llanos, E. Hertrampf, F. Cortes, A. Pardo, S.D. Grosse, and R. Uauy Cost-effectiveness of a folic acid fortification program in Chile Health Policy 83 2-3 2007 295 303 10.1016/j.healthpol.2007.01.011
46. A.-R. Sayed, D. Bourne, R. Pattinson, J. Nixon, and B. Henderson Decline in the prevalence of neural tube defects following folic acid fortification and its cost-benefit in South Africa Birth Defects Res A Clin Mol Teratol 82 4 2008 211 216 10.1002/bdra.20442
47. R. Obeid, K. Pietrzik, G.P. Oakley Jr., V. Kancherla, W. Holzgreve, and S. Wieser Preventable spina bifida and anencephaly in Europe Birth Defects Res A Clin Mol Teratol 103 9 2015 763 771 10.1002/bdra.23400
48. A. Correa-Villasenor, G.A. Satten, H. Rolka, P. Langlois, and O. Devine Random error and undercounting in birth defects surveillance data: implications for inference Birth Defects Res A Clin Mol Teratol 67 9 2003 610 616 10.1002/bdra.10110
49. J. Gahche, R. Bailey, V. Burt, and et al. Dietary supplement use among U.S. adults has increased since NHANES III (1988-1994) NCHS Data Brief 61 2011 1 8
50. National Birth Defects Prevention Network. Neural Tube Defect Ascertainment Project. 2010. www.nbdpn.org/current/2010pdf/NTD%20fact%20sheet%2001-10%20for%20website.pdf. Accessed September 16, 2015.
51. T.G. Bentley, M.C. Weinstein, W.C. Willett, and K.M. Kuntz A cost-effectiveness analysis of folic acid fortification policy in the United States Public Health Nutr 12 4 2009 455 467 10.1017/S1368980008002565
52. J. Metz, A.R. McNeil, and M. Levin The relationship between serum cobalamin concentration and mean red cell volume at varying concentrations of serum folate Clin Lab Haematol 26 5 2004 323 325 10.1111/j.1365-2257.2004.00631.x
53. K.F. Wyckoff, and V. Ganji Proportion of individuals with low serum vitamin B-12 concentrations without macrocytosis is higher in the post folic acid fortification period than in the pre folic acid fortification period Am J Clin Nutr 86 4 2007 1187 1192
54. Y.P. Qi, A.N. Do, H.C. Hamner, C.M. Pfeiffer, and R.J. Berry The prevalence of low serum vitamin B-12 status in the absence of anemia or macrocytosis did not increase among older U.S. adults after mandatory folic acid fortification J Nutr 144 2 2014 170 176 10.3945/jn.113.183095
55. T.N. Wien, E. Pike, T. Wisloff, A. Staff, S. Smeland, and M. Klemp Cancer risk with folic acid supplements: a systematic review and meta-analysis BMJ Open 2 1 2012 10.1136/bmjopen-2011-000653
56. S.E. Vollset, R. Clarke, S. Lewington, and et al. Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50,000 individuals Lancet 381 9871 2013 1029 1036 10.1016/S0140-6736(12)62001-7
57. S.G. Grupp, M.L. Greenberg, J.G. Ray, and et al. Pediatric cancer rates after universal folic acid flour fortification in Ontario J Clin Pharmacol 51 1 2011 60 65 10.1177/0091270010365553
58. A.M. Linabery, K.J. Johnson, and J.A. Ross Childhood cancer incidence trends in association with U.S. folic acid fortification (1986-2008) Pediatrics 129 6 2012 1125 1133 10.1542/peds.2011-3418
59. M.A. Canfield, J.S. Collins, L.D. Botto, and et al. Changes in the birth prevalence of selected birth defects after grain fortification with folic acid in the United States: findings from a multi-state population-based study Birth Defects Res A Clin Mol Teratol 73 10 2005 679 689 10.1002/bdra.20210
60. J.G. Ray Folic acid food fortification in Canada Nutr Rev 62 6 Pt 2 2004 35 39 10.1301/nr.2004.jun.S35-S39
61. Q. Yang, L.D. Botto, J.D. Erickson, and et al. Improvement in stroke mortality in Canada and the United States, 1990 to 2002 Circulation 113 10 2006 1335 1343 10.1161/CIRCULATIONAHA.105.570846
62. Y. Huo, X. Qin, J. Wang, and et al. Efficacy of folic acid supplementation in stroke prevention: new insight from a meta-analysis Int J Clin Pract 66 6 2012 544 551 10.1111/j.1742-1241.2012.02929.x
63. R. Zeng, C.H. Xu, Y.N. Xu, Y.L. Wang, and M. Wang The effect of folate fortification on folic acid-based homocysteine-lowering intervention and stroke risk: a meta-analysis Public Health Nutr 2014 1 8
64. Y. Huo, J. Li, X. Qin, and et al. Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: The CSPPT Randomized Clinical Trial JAMA 313 13 2015 1325 1335 10.1001/jama.2015.2274
65. S.D. Ramsey How should we value lives lost to cancer? J Natl Cancer Inst 100 24 2008 1742 1743 10.1093/jnci/djn434
66. J. Simon, S. Petrou, and A. Gray The valuation of prenatal life in economic evaluations of perinatal interventions Health Econ 18 4 2009 487 494 10.1002/hec.1375